203 related articles for article (PubMed ID: 19116447)
1. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
Hu J; Chen LJ; Liu L; Chen X; Chen PL; Yang G; Hou WL; Tang MH; Zhang F; Wang XH; Zhao X; Wei YQ
Exp Mol Med; 2008 Dec; 40(6):617-28. PubMed ID: 19116447
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
Jiang QQ; Fan LY; Yang GL; Guo WH; Hou WL; Chen LJ; Wei YQ
BMC Cancer; 2008 Aug; 8():242. PubMed ID: 18706101
[TBL] [Abstract][Full Text] [Related]
3. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
[TBL] [Abstract][Full Text] [Related]
4. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene.
Yuan Z; Liu H; Yan F; Wang Y; Gou L; Nie C; Ding Z; Lai S; Zhao Y; Zhao X; Li J; Deng H; Mao Y; Chen L; Wei Y; Zhao X
Cancer Sci; 2009 Sep; 100(9):1757-66. PubMed ID: 19575751
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
6. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
7. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Deng S; Zhang C; Yang L; Ma L
Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.
Liu Y; Chen L; He X; Fan L; Yang G; Chen X; Lin X; DU L; Li Z; Ye H; Mao Y; Zhao X; Wei Y
Int J Gynecol Cancer; 2008; 18(4):652-9. PubMed ID: 17892458
[TBL] [Abstract][Full Text] [Related]
9. Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer.
Luo H; Zhong Q; Chen LJ; Qi XR; Fu AF; Yang HS; Yang F; Lin HG; Wei YQ; Zhao X
J Cancer Res Clin Oncol; 2008 Sep; 134(9):937-45. PubMed ID: 18350317
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
11. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo.
Bai X; Cerimele F; Ushio-Fukai M; Waqas M; Campbell PM; Govindarajan B; Der CJ; Battle T; Frank DA; Ye K; Murad E; Dubiel W; Soff G; Arbiser JL
J Biol Chem; 2003 Sep; 278(37):35501-7. PubMed ID: 12816951
[TBL] [Abstract][Full Text] [Related]
12. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
Vaid M; Sharma SD; Katiyar SK
Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108
[TBL] [Abstract][Full Text] [Related]
13. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation.
Shi HS; Gao X; Li D; Zhang QW; Wang YS; Zheng Y; Cai LL; Zhong RM; Rui A; Li ZY; Zheng H; Chen XC; Chen LJ
Int J Nanomedicine; 2012; 7():2601-11. PubMed ID: 22679371
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
15. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.
Vavilala DT; Ponnaluri VK; Kanjilal D; Mukherji M
PLoS One; 2014; 9(11):e113717. PubMed ID: 25422886
[TBL] [Abstract][Full Text] [Related]
17. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death.
Peng PL; Kuo WH; Tseng HC; Chou FP
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):529-42. PubMed ID: 18207031
[TBL] [Abstract][Full Text] [Related]
18. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
Li Z; Liu Y; Zhao X; Pan X; Yin R; Huang C; Chen L; Wei Y
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
[TBL] [Abstract][Full Text] [Related]
19. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]